Market Size of Neuroscience Antibodies and Assays Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 10.20 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Neuroscience Antibodies & Assays Market Analysis
The neuroscience antibodies and assays market is expected to register a CAGR of around 10.2% during the forecast period.
- COVID-19 had a significant impact on the neuroscience antibodies and assays market in the initial phases since the market faced a decline in growth due to the lockdown, which caused the temporary closing of many laboratory facilities conducting neuroscience assays. For instance, according to an article published in April 2022 by PubMed, researchers faced decreased neuroscience research funding, resource limitations, laboratory and hospital access restrictions, and reductions in available personnel during the pandemic.
- The market will likely witness growth in the coming years due to the high prevalence of neurological diseases, research and developments, and technological advances in the neuroscience antibodies and assay market. Moreover, patients infected with COVID-19 have developed long-term neurological complications, which can drive market growth. Future market expansion is anticipated to be driven by the increasing demand for neuroscience assays and antibodies due to the surge in neuroscience advancements following the pandemic.
- The high prevalence of neurological diseases is one of the major driving factors for market growth, as these are likely to lead to the increased use of immunoassays to detect neurological diseases accurately. For instance, according to Parkinson's Foundation, as of 2022, nearly one million people in the United States are living with Parkinson's disease (PD). This number is expected to rise to 1.2 million by 2030. Parkinson's is the second-most common neurodegenerative disease after Alzheimer's disease. More than 10 million individuals worldwide also have Parkinson's disease. Hence, the high prevalence of neurological diseases will likely boost the market growth.
- Furthermore, growth in the pharmaceutical and biotechnology industries will likely boost market growth over the forecast period. For instance, according to the Indian Economic Survey 2021, the domestic market is expected to triple in the next decade. India's domestic pharmaceutical market stood at USD 42 billion in 2021 and is likely to reach USD 65 billion by 2024 and increase to USD 120-130 billion by 2030.
- Furthermore, neuroscience research relies heavily on antibodies that help identify and elucidate cellular, molecular, and biochemical reactions, which may lead to a better understanding of various neuroscience processes and neuronal diseases. This could increase the growth of the market over the forecast period.
- According to an article published in December 2021 by Oxford Academic, antibody-based treatments are increasingly common in treating neuroinflammatory illnesses. The specificity-conferring antigen-binding fragment (Fab) and the crystallizable fragment (Fc) driving antibody function affect the efficiency of antibody-based therapeutic platforms. Hence, increased research activities relating to neurology antibodies and assays will likely boost market growth over the forecast period.
- Hence, due to the rising incidence of neurological diseases and increasing research and development activities, the neuroscience antibodies and assays market is anticipated to witness growth over the forecast period. However, the high cost associated with the production of antibodies restrains the market growth.
Neuroscience Antibodies & Assays Industry Segmentation
As per the scope of the report, in neuroscience research, antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. Neuroscience assays are immunoassays and arrays for the quantitative or semi-quantitative measurement of neurologically important protein biomarkers.
The neuroscience antibodies and assays market is segmented by product type (consumables and instruments), technology (immunoassays/immunochemistry, molecular diagnostics, and other technologies), end user (academic and research institutes, pharmaceutical and biotechnology companies, and other end users) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product Type | |
Consumables | |
Instruments |
By Technology | |
Immunoassays/Immunochemistry | |
Molecular Diagnostics | |
Other Technologies |
By End User | |
Academic and Research Institutes | |
Pharmaceutical and Biotechnology Companies | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Neuroscience Antibodies and Assays Market Size Summary
The neuroscience antibodies and assays market is poised for significant growth, driven by the increasing prevalence of neurological diseases and advancements in research and technology. The market experienced initial setbacks due to the COVID-19 pandemic, which disrupted laboratory operations and research funding. However, the demand for neuroscience assays and antibodies is expected to rise as the pandemic has led to long-term neurological complications in some patients. The market's expansion is further supported by the growing pharmaceutical and biotechnology sectors, which are investing in neuroscience research to better understand and treat neurological disorders. Immunoassays, a key component of this market, are gaining traction due to their effectiveness in diagnosing and monitoring neurological diseases, supported by technological advancements and government initiatives in genomics and proteomics.
North America is anticipated to hold a significant share of the global market, fueled by the rising incidence of neurological diseases and robust research and development activities in the region. The market is moderately competitive, with major players like Thermo Fisher Scientific and Bio-Rad Laboratories leading the charge. Recent product launches and innovative testing methods, such as the Neurofilament Light Chain blood test, are expected to enhance diagnostic capabilities and drive market growth. The market's trajectory is also influenced by increased funding and research initiatives, particularly in understanding and treating conditions like Alzheimer's and Parkinson's diseases. As the market evolves, the focus on developing novel antibodies and assays continues to be a critical factor in addressing the challenges posed by neurological disorders.
Neuroscience Antibodies and Assays Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Incidence of Neurological Diseases
-
1.2.2 Increasing Research and Development Activities
-
1.2.3 Growth in the Pharmaceutical and Biotechnology Industries
-
-
1.3 Market Restraints
-
1.3.1 High Cost Associated with the Production of Antibodies
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Product Type
-
2.1.1 Consumables
-
2.1.2 Instruments
-
-
2.2 By Technology
-
2.2.1 Immunoassays/Immunochemistry
-
2.2.2 Molecular Diagnostics
-
2.2.3 Other Technologies
-
-
2.3 By End User
-
2.3.1 Academic and Research Institutes
-
2.3.2 Pharmaceutical and Biotechnology Companies
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Neuroscience Antibodies and Assays Market Size FAQs
What is the current Neuroscience Antibodies and Assays Market size?
The Neuroscience Antibodies and Assays Market is projected to register a CAGR of 10.20% during the forecast period (2024-2029)
Who are the key players in Neuroscience Antibodies and Assays Market?
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Cell Signaling Technology, Inc and Merck KGaA are the major companies operating in the Neuroscience Antibodies and Assays Market.